Paolo Airò Selected Research

Paolo Airò Research Topics

Disease

21	Systemic Scleroderma (Systemic Sclerosis) 05/2024 - 12/2006
11	Rheumatoid Arthritis 01/2024 - 05/2010
5	Interstitial Lung Diseases (Interstitial Lung Disease) 05/2024 - 08/2015
4	digital ulcers 05/2024 - 03/2010
4	Autoimmune Diseases (Autoimmune Disease) 07/2021 - 12/2006
3	Arthritis (Polyarthritis) 05/2024 - 08/2015
3	Neoplasms (Cancer) 11/2021 - 01/2017
3	COVID-19 02/2021 - 01/2020
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 12/2006
3	Diffuse Scleroderma (Progressive Systemic Sclerosis) 10/2020 - 12/2006
3	Infections 11/2019 - 06/2009
3	Inflammation (Inflammations) 01/2017 - 09/2007
2	Hypertension (High Blood Pressure) 01/2024 - 01/2017
2	Synovitis 11/2022 - 01/2018
2	Rupture 07/2021 - 05/2017
2	Myositis (Idiopathic Inflammatory Myopathies) 12/2020 - 08/2015
2	Lymphopenia (Lymphocytopenia) 07/2020 - 08/2010
2	Rheumatic Diseases (Rheumatism) 10/2018 - 01/2017
2	Gastric Antral Vascular Ectasia (Watermelon Stomach) 10/2018 - 07/2010
2	Antisynthetase syndrome 02/2017 - 08/2015
1	Fibrosis (Cirrhosis) 05/2024
1	Hypercholesterolemia 01/2024
1	Cholangitis 10/2023
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 10/2023
1	Pulmonary Hypertension 08/2023
1	Pulmonary Arterial Hypertension 08/2023
1	Breast Neoplasms (Breast Cancer) 07/2021
1	Disease Progression 10/2020
1	Respiratory Insufficiency (Respiratory Failure) 07/2020
1	Pneumonia (Pneumonitis) 07/2020
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 01/2020
1	Liver Diseases (Liver Disease) 11/2019
1	Necrosis 01/2019
1	Type 2 Diabetes Mellitus (MODY) 12/2018
1	Diabetes Mellitus 12/2018
1	Contracture 10/2018
1	Fungal Lung Diseases 11/2017
1	Hepatitis B 10/2017
1	Vascular System Injuries 01/2017
1	Vascular Remodeling 12/2016
1	Essential Hypertension 12/2016
1	Mixed Connective Tissue Disease (MCTD) 09/2016

Drug/Important Bio-Agent (IBA)

10	AntibodiesIBA 10/2023 - 07/2010
8	AutoantibodiesIBA 01/2024 - 12/2006
8	Abatacept (Orencia)FDA Link 11/2022 - 05/2010
5	RNA Polymerase IIIIBA 07/2021 - 07/2010
3	Rituximab (Mabthera)FDA Link 05/2024 - 09/2016
3	Proteins (Proteins, Gene)FDA Link 01/2024 - 09/2007
3	EnzymesIBA 10/2023 - 10/2018
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2020
3	Antirheumatic Agents (DMARD)IBA 11/2019 - 08/2016
2	Type I DNA Topoisomerases (Topoisomerase I)IBA 05/2024 - 10/2018
2	Rheumatoid FactorIBA 01/2024 - 04/2014
2	tocilizumab (atlizumab)FDA Link 01/2023 - 07/2020
2	ChemokinesIBA 11/2022 - 09/2007
2	SiliconesIBA 07/2021 - 05/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 06/2009
2	belimumabIBA 01/2021 - 01/2019
2	ametantrone (HAQ)IBA 10/2020 - 01/2018
2	Monoclonal AntibodiesIBA 07/2020 - 01/2019
2	Antiviral Agents (Antivirals)IBA 11/2019 - 10/2017
2	InterferonsIBA 04/2015 - 12/2006
1	Indicators and Reagents (Reagents)IBA 05/2024
1	Retinaldehyde (Retinal)IBA 01/2024
1	Peptides (Polypeptides)IBA 01/2024
1	anticentromere antibodyIBA 10/2023
1	trioctyl phosphine oxide (TOPO)IBA 08/2023
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2023
1	nintedanibIBA 01/2023
1	anti-scl-70 autoantibodiesIBA 11/2022
1	AntigensIBA 11/2022
1	Iloprost (Ventavis)FDA Link 02/2021
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2021
1	Biosimilar PharmaceuticalsIBA 12/2020
1	Ferritins (Ferritin)IBA 07/2020
1	Interleukin-6 (Interleukin 6)IBA 07/2020
1	C-Reactive ProteinIBA 07/2020
1	Fibrinogen (Factor I)FDA Link 07/2020
1	Dihydrotachysterol (AT 10)IBA 02/2020
1	Colchicine FDA LinkGeneric 01/2020
1	Tumor Necrosis Factor InhibitorsIBA 01/2019
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2019
1	Interleukin-1 (Interleukin 1)IBA 01/2019
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2019
1	Liraglutide FDA Link 12/2018
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 12/2018
1	IncretinsIBA 12/2018
1	Exenatide (Byetta)FDA Link 12/2018
1	Glucagon-Like Peptides (Enteroglucagon)IBA 12/2018
1	ImmunosorbentsIBA 10/2018
1	Angiotensin IIIBA 01/2017
1	AntioxidantsIBA 12/2016
1	Antihypertensive Agents (Antihypertensives)IBA 12/2016
1	lercanidipineIBA 12/2016
1	1,4-dihydropyridine (dihydropyridine)IBA 12/2016
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 12/2016

Therapy/Procedure

8	Therapeutics 01/2024 - 08/2010
2	Breast Implants (Breast Implant) 07/2021 - 05/2017
1	Liver Transplantation 10/2023
1	Intravenous Administration 07/2020